Perrigo (PRGO) Revenue Growth (1y) (2013 - 2026)
Perrigo (PRGO) Revenue Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.34% |
| 3 | Zoetis | 32.39 Bn | 30.45 Bn | 1.62 Bn | 2.91% |
| 4 | Takeda Pharmaceutical | 27.59 Bn | 23.53 Bn | 4.39 Bn | -11.85% |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn | -1.62% |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.46 Bn | 1.16 Bn | 7.85% |
| 8 | Neurocrine Biosciences | 18.00 Bn | 16.69 Bn | 800.70 Mn | 42.25% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 14.92% |
| 10 | Perrigo | 1.45 Bn | 1.09 Bn | 325.50 Mn | -7.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -7.16% |
| Dec 31, 2025 | -2.52% |
| Sep 27, 2025 | -4.06% |
| Jun 28, 2025 | -0.86% |
| Mar 29, 2025 | -3.53% |
| Dec 31, 2024 | -1.61% |
| Sep 28, 2024 | -3.23% |
| Jun 29, 2024 | -10.69% |
| Mar 30, 2024 | -8.43% |
| Dec 31, 2023 | 0.14% |
| Sep 30, 2023 | 2.15% |
| Jul 1, 2023 | 6.37% |
| Apr 1, 2023 | 9.98% |
| Dec 31, 2022 | 4.56% |
| Oct 1, 2022 | 5.51% |
| Jul 2, 2022 | 14.33% |
| Apr 2, 2022 | 6.39% |
| Dec 31, 2021 | -14.32% |
| Oct 2, 2021 | 3.96% |
| Jul 3, 2021 | 3.40% |